Equasens SA
PAR:EQS

Watchlist Manager
Equasens SA Logo
Equasens SA
PAR:EQS
Watchlist
Price: 44.85 EUR -1.54% Market Closed
Market Cap: 674.1m EUR
Have any thoughts about
Equasens SA?
Write Note

Intrinsic Value

The intrinsic value of one EQS stock under the Base Case scenario is 72.17 EUR. Compared to the current market price of 44.85 EUR, Equasens SA is Undervalued by 38%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

EQS Intrinsic Value
72.17 EUR
Undervaluation 38%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Equasens SA

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for EQS cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about EQS?
Bearish
Neutral
Bullish
Discover Undervalued Stocks
Health Care Industry

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Equasens SA

Provide an overview of the primary business activities
of Equasens SA.

What unique competitive advantages
does Equasens SA hold over its rivals?

What risks and challenges
does Equasens SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Equasens SA.

Provide P/S
for Equasens SA.

Provide P/E
for Equasens SA.

Provide P/OCF
for Equasens SA.

Provide P/FCFE
for Equasens SA.

Provide P/B
for Equasens SA.

Provide EV/S
for Equasens SA.

Provide EV/GP
for Equasens SA.

Provide EV/EBITDA
for Equasens SA.

Provide EV/EBIT
for Equasens SA.

Provide EV/OCF
for Equasens SA.

Provide EV/FCFF
for Equasens SA.

Provide EV/IC
for Equasens SA.

Show me price targets
for Equasens SA made by professional analysts.

What are the Revenue projections
for Equasens SA?

How accurate were the past Revenue estimates
for Equasens SA?

What are the Net Income projections
for Equasens SA?

How accurate were the past Net Income estimates
for Equasens SA?

What are the EPS projections
for Equasens SA?

How accurate were the past EPS estimates
for Equasens SA?

What are the EBIT projections
for Equasens SA?

How accurate were the past EBIT estimates
for Equasens SA?

Compare the revenue forecasts
for Equasens SA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Equasens SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Equasens SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Equasens SA compared to its peers.

Compare the P/E ratios
of Equasens SA against its peers.

Discuss the investment returns and shareholder value creation
comparing Equasens SA with its peers.

Analyze the financial leverage
of Equasens SA compared to its main competitors.

Show all profitability ratios
for Equasens SA.

Provide ROE
for Equasens SA.

Provide ROA
for Equasens SA.

Provide ROIC
for Equasens SA.

Provide ROCE
for Equasens SA.

Provide Gross Margin
for Equasens SA.

Provide Operating Margin
for Equasens SA.

Provide Net Margin
for Equasens SA.

Provide FCF Margin
for Equasens SA.

Show all solvency ratios
for Equasens SA.

Provide D/E Ratio
for Equasens SA.

Provide D/A Ratio
for Equasens SA.

Provide Interest Coverage Ratio
for Equasens SA.

Provide Altman Z-Score Ratio
for Equasens SA.

Provide Quick Ratio
for Equasens SA.

Provide Current Ratio
for Equasens SA.

Provide Cash Ratio
for Equasens SA.

What is the historical Revenue growth
over the last 5 years for Equasens SA?

What is the historical Net Income growth
over the last 5 years for Equasens SA?

What is the current Free Cash Flow
of Equasens SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Equasens SA.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Equasens SA

Current Assets 132.3m
Cash & Short-Term Investments 54.7m
Receivables 67.3m
Other Current Assets 10.3m
Non-Current Assets 261.8m
Long-Term Investments 95.1m
PP&E 32.9m
Intangibles 130.3m
Other Non-Current Assets 3.5m
Current Liabilities 108.1m
Accounts Payable 16.1m
Other Current Liabilities 92m
Non-Current Liabilities 66.6m
Long-Term Debt 44.7m
Other Non-Current Liabilities 22m
Efficiency

Earnings Waterfall
Equasens SA

Revenue
219.8m EUR
Cost of Revenue
-69.1m EUR
Gross Profit
150.6m EUR
Operating Expenses
-95.4m EUR
Operating Income
55.2m EUR
Other Expenses
-8.2m EUR
Net Income
47m EUR

Free Cash Flow Analysis
Equasens SA

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

EQS Profitability Score
Profitability Due Diligence

Equasens SA's profitability score is 66/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Exceptional 3-Year Average ROE
Positive Operating Income
66/100
Profitability
Score

Equasens SA's profitability score is 66/100. The higher the profitability score, the more profitable the company is.

EQS Solvency Score
Solvency Due Diligence

Equasens SA's solvency score is 69/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Negative Net Debt
69/100
Solvency
Score

Equasens SA's solvency score is 69/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

EQS Price Targets Summary
Equasens SA

Wall Street analysts forecast EQS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for EQS is 85.1 EUR with a low forecast of 64.94 EUR and a high forecast of 110.25 EUR.

Lowest
Price Target
64.94 EUR
45% Upside
Average
Price Target
85.1 EUR
90% Upside
Highest
Price Target
110.25 EUR
146% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for EQS?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for EQS is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Equasens SA Logo
Equasens SA

Country

France

Industry

Health Care

Market Cap

674.2m EUR

Dividend Yield

2.79%

Description

Equasens engages in the development of management software packages for drugstores. The company is headquartered in Villers-Les-Nancy, Grand Est. The company went IPO on 2000-10-20. The firm is engaged in the development and integration of management software packages for drugstores. The company offers all IT (Information Technology) and High-Tech fields related to Health and in specialized fields which are associated to it such as IT for pharmacies, solutions for e-Health, solutions for pharmaceutical industry, solutions for patients etc. The firm operates in four divisions that includes Europe Pharmacy Solutions Division including France Pharmacy Section and Belgium and Luxembourg Pharmacy Section, Solutions for sanitary and medico-social entities Division, e-Health Solutions Division including e-Laboratories section, e-Patients section and e-Connect section and Fintech Division.

Contact

GRAND EST
Villers-les-Nancy
5 Allee de Saint-Cloud
+33383159595
pharmagest.com

IPO

2000-10-20

Employees

1 190

Officers

Founder & Chairman of the Board
Mr. Thierry Chapusot
Deputy CEO, Deputy MD, Director of Healthcare, Medical & Social Software Division and Director
Mr. Grégoire De Rotalier
Chief Executive Officer & Director
Mr. Denis Supplisson
Director
Mr. Dominique Pautrat
Group Chief Administrative & Financial Officer
Ms. Frederique Schmidt
Head of Communications
Ms. Noelle Stoulig
Show More
Chief Human Resources Officer
Ms. Sabrina Gharbi
Head of the Medical Solutions Division
Mr. Dominique Goursaud
Deputy MD & Head of the Pharmagest Division
Mr. Damien Valicon
Show Less

See Also

Discover More
What is the Intrinsic Value of one EQS stock?

The intrinsic value of one EQS stock under the Base Case scenario is 72.17 EUR.

Is EQS stock undervalued or overvalued?

Compared to the current market price of 44.85 EUR, Equasens SA is Undervalued by 38%.

Back to Top